Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Generation and characterisation of a PARP-1-deficient heart endothelial cell line

A. Carrillo, Y. Monreal, L. Marin, P. Ramirez, P. Parrilla, J. Yelamos

Med Sci Monit 2003; 9(1): 8-0 :: ID: 15054

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) has been involved in endothelial cell dysfunction associated to various pathophysiological conditions such as reperfusion [1], endotoxic shock [2], diabetes [3] and aging [4]. The intrinsic mechanism of PARP-1-mediated endothelial cell dysfunction might be related to PARP-1 overactivation and ATP depletion. An alternative way in which PARP-1 may influence endothelial cell function could involved transcription regulation [5]. Primary endothelial cells have a limit life span in culture. After 5-6 passages, they tend to de-differentiate and eventually reach senescence which limits their use in studies of endothelial cell function. The aim of this work was to establish an immortalized PARP-1-deficient endothelial cell line. Primary murine heart endothelial cells (MHEC) were isolated from PARP-1 knockout mice [6] (kindly provided by Dr. de Murcia) by collagenase treatment and cell sorting of ICAM-2-positive cells. MHEC were transfected with the pRNS-1 plasmid encoding the SV40 genome (kindly provided by Dr. Ozer) and a clone was selected on the basis of their morphological and phenotypical features. Flow cytometry analysis of this cell line (HYKO6) demonstrated constitutive expression of MHC-Class I, CD105, ICAM-2, and VCAM-1 antigens. Moreover, the HYKO6 cell line was able to up-regulate the expression of E-selectin in response to TNF-a. This cell line has been maintained in culture for many passages without signs of senescence and with preserved characteristics of primary endothelial cells. The HYKO6 cell line will provide a useful tool to study the role played by PARP-1 in endothelial cell dysfunction.References: 1.Szabó C et al: Cir Res, 2002; 90: 100-106 2.Szabó C et al: J Clin Invest, 1997; 100: 723-735 3.García Soriano F et al: Nat Med, 2001; 7: 108-113 4.Pacer P et al: Br J Pharmacol, 2002; 135: 1347-1350 5.Chiarugi A: Trends Pharmacol Sci, 2002; 23: 122-129 6.Menissier de Murcia J et al: Proc Natl Acad Sci USA, 1997; 94: 7303-7307

Keywords: PARP-1, Endothelium, Cell Line

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

12 Mar 2024 : Clinical Research  

Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.943126  

0:00

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

12 Mar 2024 : Review article  

Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies

Med Sci Monit In Press; DOI: 10.12659/MSM.943240  

0:00

12 Mar 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Med Sci Monit In Press; DOI: 10.12659/MSM.943360  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750